Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy o... और पढ़ें

Clinical Trial: Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749300) titled 'Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Blee... और पढ़ें

Clinical Trial: A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748624) titled 'A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants Wi... और पढ़ें

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mu... और पढ़ें

Clinical Trial: Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749924) titled 'Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-S... और पढ़ें

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab ... और पढ़ें

Clinical Trial: A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749586) titled 'A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Soli... और पढ़ें

Clinical Trial: LIVER STEATOSIS AND FIBROSIS IN NON-CELIAC WHEAT SENSITIVITY PATIENTS: A PROSPECTIVE STUDY

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750535) titled 'LIVER STEATOSIS AND FIBROSIS IN NON-CELIAC WHEAT SENSITIVITY PATIENTS: A PROSPECTIVE STUDY' ... और पढ़ें

Clinical Trial: SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748611) titled 'SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable... और पढ़ें

Clinical Trial: Virtual Reality Exergaming During Work Breaks in Office Employees

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749196) titled 'Virtual Reality Exergaming During Work Breaks in Office Employees' on Aug. 01. Brief Summar... और पढ़ें

• ««
• «
• 1321
• 1322
• 1323
• 1324
• 1325
• 1326
• 1327
• 1328
• 1329
• 1330
• »
• »»